ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00099216
Recruitment Status : Completed
First Posted : December 10, 2004
Last Update Posted : November 17, 2011
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2005
  Actual Study Completion Date : November 2005